BowLeven Falls on Share Sale as Cameroon Decision Pushed to 2014

BowLeven Plc (BLVN), a U.K. oil and gas explorer in West Africa, slumped to a 4 1/2-year low in London trading after agreeing to sell equity amid delays to a project in Cameroon.

The shares tumbled 16 percent to 44.5 pence at 9:14 a.m. local time, the lowest price since April 2009. Trading volumes were already more than four times the three-month daily average.

BowLeven conditionally agreed to sell as many as 11.8 million pounds ($18.8 million) of equity at 45 pence a share, it said today in a statement. That compares with yesterday’s closing price of 52.8 pence. It also may raise further funds from current and new investors.

BowLeven, trading almost 90 percent below its peak in 2011, has sought to sell stakes in licenses to bolster funds. The Edinburgh-based company has suffered from delays at a proposed fertilizer-plant project in Cameroon, which it plans to provide with gas.

“The addition of further flexibility remains a priority for the group,” Chief Executive Officer Kevin Hart said in the statement. “Active discussions are under way with a range of potential financial providers, and with a number of specific parties regarding potential farmouts.”

A decision on the fertilizer plant, scheduled to start operating in 2016, has been pushed back to the middle of next year from the end of 2013. The company, which previously said it was fully funded until the final investment decision, said today it had about $20 million in cash at the end of June and no debt.

BowLeven increased the resource estimate for the Etinde gas discovery that will feed the plant by 30 percent and said there are possibilities to use the fuel beyond the plant, which would be built by Germany’s Ferrostaal GmbH. U.K. oil-services company Petrofac Ltd. (PFC) has agreed to help fund the project if it gets approval.

To contact the reporter on this story: Brian Swint in London at

To contact the editor responsible for this story: Will Kennedy at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.